Canadian Cannabis Producers Recover 2018 Losses with 34% Rally in August

After plunging 13% in July and then extending the correction that began in January into mid-August, Canadian cannabis producers rallied sharply in the back half of the month, with the Canadian Cannabis LP Index increasing 34.2% for the entire month to 1022.02:

The recovery, which followed the announcement of the pending C$5 billion investment by Constellation Brands (NYSE: STZ) into Canopy Growth (TSX: WEED) (NYSE: CGC), leaves the index, which had been down 27.3% year-to-date through August 14th , up 1.7% in the first eight months of the year:

Beyond the news of the big investment by Constellation Brands, other important items included supply agreement announcements from Ontario and Nova Scotia as well as news that Ontario will be moving from a government-run distribution system to one that includes private retailers. The program, which is still being developed, isn’t expected to launch until April, with the province selling only online from October until then. Additionally, rumors that Diageo (NYSE: DEO) is on the hunt for an acquisition or strategic partnership fueled speculation. Finally, Invictus MD Strategies (TSXV: GENE) (OTC: IVITF) was able to lock down a $25.5 million debt financing at Prime plus 2% from ATB Financial to fund an expansion at its Acreage Pharms, another example of traditional financing opening up to the industry.

The index, which included 39 publicly-traded licensed producers that traded in Canada at the end of July, with equal weighting, is rebalanced monthly. Each of the members is also included in a sub-index, with four in the Canadian Cannabis LP Tier 1 Index  twenty-one in the Canadian Cannabis LP Tier 2 Index and fourteen in the Canadian Cannabis LP Tier 3 Index during the month.

Tier 1

Tier 1, which includes the LPs that are generating sales of at least C$4 million per quarter, rose 49.7% in August and is now up 48.3% year-to-date. This group included Aphria (TSX: APH) (OTC: APHQF), Aurora Cannabis (TSX: ACB) (OTC: ACBFF), CannTrust (CSE: TRST) (OTC: CNTTF) and Canopy Growth. Within the group, Canopy Growth, which rose 73.8%, posted the best return among the four and is now up 100.5% in 2018. CannTrust and Aphria returned 52.3% and 47.5%, respectively, while Aurora Cannabis, returning 25.4%, lagged its peers for the second straight month.

Tier 2

Tier 2, which includes the remaining LPs that are permitted to generate sales, rose 35.5%, its first positive return since January, and is now up 3.7% year-to-date. Hiku Brands (CSE: HIKU) (OTC: DJACF) was the best performer, as its stock tracked Canopy Growth, which is acquiring it for .046 shares of its stock for each share of Hiku Brands.  Cronos Group (TSX: CRON) (NASDAQ: CRON) reported record sales and rallied in excess of 60%. THC Biomed (CSE: THC) (OTC: THCBF) and 48North (TSXV: NRTH) (OTC: NCNNF) were the worst performers among the group.

Tier 3

Tier 3, which includes the LPs that are licensed to cultivate but not yet approved to sell, rose 27.8% and remains the weakest performer in 2018, down 9.1% year-to-date through the end of August. RavenQuest (CSE: RQB) (OTC: RVVQF) recovered a large portion of its year-to-date losses as it more than doubled. FSD Pharma (CSE: HUGE) (OTC: FSDDF) gained more than 64%. Two Tier 3 names, both relative newcomers to the public markets, declined, including Pure Global Cannabis (TSXV: PURE) (OTC: PRCNF) and Sproutly (CSE: SPR) (OTC: SRUTF).

The returns for the overall sector varied greatly, with eleven stocks increasing in value by more than 10%, while ten rose less than 10%, with three declining:

For September, the overall index had one addition, Ascent Industries (CSE: ASNT) (OTC: PGTMF), which has been added to Tier 3. The company operates in Canada as the owner of Agrima and has facilities in Oregon and Nevada. It has also submitted an application in Denmark. With its pending acquisition now finalized, Hiku Brands has been removed from the index. Additionally,  INDIVA (TSXV: NDVA) (OTC: NDVAF) and Viridium Pacific (TSXV: VIR) (OTC: VIRFF) have moved up to Tier 2 following the amendments to their Health Canada licenses permitting them to sell. Finally, readers should be aware that Tilray (NASDAQ: TLRY), with no Canadian listing, is not eligible for inclusion in the index, which is denominated in Canadian dollars.

In the next monthly review, we will summarize the performance for September and discuss any additions or deletions. Be sure to bookmark the pages to stay current on LP stock price movements within the day or from day-to-day.

Exclusive article by Alan Brochstein, CFA
Alan Brochstein, CFA
Based in Houston, Alan leverages his experience as founder of online community 420 Investor, the first and still largest due diligence platform focused on the publicly-traded stocks in the cannabis industry. With his extensive network in the cannabis community, Alan continues to find new ways to connect the industry and facilitate its sustainable growth. At New Cannabis Ventures, he is responsible for content development and strategic alliances. Before shifting his focus to the cannabis industry in early 2013, Alan, who began his career on Wall Street in 1986, worked as an independent research analyst following over two decades in research and portfolio management. A prolific writer, with over 650 articles published since 2007 at Seeking Alpha, where he has 70,000 followers, Alan is a frequent speaker at industry conferences and a frequent source to the media, including the NY Times, the Wall Street Journal, Fox Business, and Bloomberg TV. Contact Alan: Twitter | Facebook | LinkedIn | Email

Get Our Sunday Newsletter